Clarivate(CLVT)

Search documents
Clarivate Recognized for Excellence in Trademark Business in the WTR 1000 2025
Prnewswire· 2025-02-10 14:30
Highly recommended in trademark management, searching and watching, renewals and recordals LONDON, Feb. 10, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has been recognized by the World Trademark Review for three categories in the WTR 1000 2025 . This guide identifies the top trademark professionals and firms in key jurisdictions around the globe. Clarivate has been named as highly recommended in the following practice areas : Trademark Managemen ...
Clarivate Selected by National and University Library in Zagreb, Croatia to Create a Unified National Library Platform
Prnewswire· 2025-02-05 08:00
Software-as-a-Service, cloud-based library services and discovery platform to be implemented in nine universities and 82 academic and research libraries across Croatia LONDON, Feb. 5, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that the National and University Library in Zagreb has selected Clarivate to provide its unified library services and discovery platform. The National and University Library in Zagreb (NSK) is Croatia's le ...
Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market
Prnewswire· 2025-02-04 08:00
New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence and BioWorld by Clarivate, today published a new e-book, Pulsed field ablation: stunning growth shocks the atrial fibrillation market. The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcas ...
Clarivate identifies top 50 universities powering global innovation
Prnewswire· 2025-01-30 08:00
Report from the Institute for Scientific Information shows how academic research drives global innovation and benefits societyLONDON, Jan. 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released The top 50 universities powering global innovation report which analyzes the critical role of research in shaping global industrial innovation and societal impact, using data and expert insights derived from academic research and patent citations. ...
The British Library Selects Clarivate to Provide Library Services and Discovery Platforms
Prnewswire· 2025-01-28 08:00
Achieving more unified and secure workflows with cloud-based Alma, Primo and Rapido library software solutions from Clarivate LONDON, Jan. 28, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces that the British Library has selected Clarivate to provide its library services and discovery platforms to create a more cohesive, streamlined and secure experience. The British Library will implement Alma, Primo VE and Rapido. Founded in 1973, th ...
Clarivate to Report Fourth Quarter and Full Year 2024 Results on February 19, 2025
Prnewswire· 2025-01-22 13:45
LONDON, Jan. 22, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the fourth quarter and full year 2024 before the market opens on Wednesday, February 19, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern ...
Does Clarivate (CLVT) Have the Potential to Rally 29.13% as Wall Street Analysts Expect?
ZACKS· 2025-01-16 16:01
Shares of Clarivate PLC (CLVT) have gained 1.6% over the past four weeks to close the last trading session at $5.08, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $6.56 indicates a potential upside of 29.1%.The average comprises eight short-term price targets ranging from a low of $4 to a high of $8, with a standard deviation of $1.45. While the lowest estimate indicates a dec ...
BioWorld by Clarivate Releases Comprehensive 2024 Year in Review
Prnewswire· 2025-01-16 08:00
Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in Review series. This multipart special report offers an in-depth analysis of the therapeutic trends, regulatory actions and economic shifts that defined biopharma, med tech and scientific innovation over the past year while fo ...
Post-marketing Pharmacovigilance and Medical Information Market Research 2024: Rising Adverse Drug Reactions (ADRs) and Expanding Use of Biologics and Specialty Drugs Fueling Growth - Forecast to 2034
GlobeNewswire News Room· 2025-01-14 16:40
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Post-marketing Pharmacovigilance and Medical Information Market by Type by Service, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.The global post-marketing pharmacovigilance and medical information market size was estimated to be USD 6.22 billion in 2023 and is expected to reach USD 16.99 billion by 2034 with a CAGR of 9.56% during the forecast period 2024-2034. The market will grow as a result of factors such as rising ...
Clarivate Launches DRG Fusion - A New Life Sciences Analytics Product Powered by Real-World Data
Prnewswire· 2025-01-14 08:10
New modular analytics solution empowers commercial teams to optimize strategies and improve patient outcomes LONDON, Jan. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG Fusion, an innovative platform to support commercial analytics in life sciences. Powered by integrated real-world data and built by clinical and data science experts, Fusion provides biopharma and medtech organizations with the tools to understan ...